GEN Exclusives

More »

GEN Poll

More »
Sep 21, 2009

Stem Cell Research and Applications

The 2009 Lasker Awards honored two scientists who developed nuclear reprogramming, a process that instructs specialized adult cells to form pluripotent stem cells. This has been widely hailed in the life science research community and the biotech/biopharma industry as one of the most significant findings of the past decade. While embryonic stem cell research has been plagued by ethical concerns, some believe that the newfound ability to induce pluripotency in adult stem cells will lead to breakthroughs in the therapeutic applications of stem cells. So we want to know which type of stem cells you think will win the race.

Which type of stem cells will be the first to move from the laboratory into clinical testing?

Embryonic stem cells
Induced pluripotent stem cells
Adult stem cells
None of the above

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »